Penn researchers find treatment for MS also reduces vision loss in MS patients
According to a study that appears in the April 17 issue of Neurology, researchers at the University of Pennsylvania School of Medicine have found that natalizumab (TYSABRI) -- a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS) -- also reduces vision loss in patients with relapsing MS. Vision loss is one of the most common and disabling symptoms of MS.
[ Ga naar het volledige artikel toe ]
[Reinig uw lichaam met de Chlorella alg -
100% plantaardig ]